| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,515 |
17,860 |
$837K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
7,447 |
6,348 |
$360K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,897 |
5,073 |
$329K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,737 |
6,161 |
$210K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
8,395 |
7,229 |
$169K |
| 87634 |
|
1,151 |
954 |
$45K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
669 |
561 |
$31K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
290 |
286 |
$27K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,412 |
2,814 |
$26K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
33 |
33 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
760 |
609 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
90 |
81 |
$940.47 |
| 36415 |
Collection of venous blood by venipuncture |
698 |
549 |
$824.99 |
| 81003 |
|
335 |
262 |
$309.46 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
46 |
26 |
$286.58 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,226 |
1,021 |
$262.60 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
274 |
220 |
$178.34 |
| 87430 |
|
14 |
12 |
$142.66 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
154 |
134 |
$110.49 |
| 80053 |
Comprehensive metabolic panel |
15 |
13 |
$65.00 |